ATE332140T1 - Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen - Google Patents

Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen

Info

Publication number
ATE332140T1
ATE332140T1 AT01900503T AT01900503T ATE332140T1 AT E332140 T1 ATE332140 T1 AT E332140T1 AT 01900503 T AT01900503 T AT 01900503T AT 01900503 T AT01900503 T AT 01900503T AT E332140 T1 ATE332140 T1 AT E332140T1
Authority
AT
Austria
Prior art keywords
steroidic
structures
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
AT01900503T
Other languages
English (en)
Inventor
Barry Victor Lloyd Potter
Avenue Robinson
Michael John Reed
Walter Elger
Gudrun Roddersen
Henrich-Thomas Proske
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0000792A external-priority patent/GB0000792D0/en
Priority claimed from GB0002115A external-priority patent/GB0002115D0/en
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE332140T1 publication Critical patent/ATE332140T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01900503T 2000-01-14 2001-01-11 Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen ATE332140T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0000792A GB0000792D0 (en) 2000-01-14 2000-01-14 Composition
GB0002115A GB0002115D0 (en) 2000-01-28 2000-01-28 Composition
US21873000P 2000-07-17 2000-07-17

Publications (1)

Publication Number Publication Date
ATE332140T1 true ATE332140T1 (de) 2006-07-15

Family

ID=27255470

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900503T ATE332140T1 (de) 2000-01-14 2001-01-11 Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen

Country Status (26)

Country Link
EP (1) EP1248626B1 (de)
JP (1) JP2003519658A (de)
KR (1) KR20020087930A (de)
CN (1) CN1404394A (de)
AR (1) AR028196A1 (de)
AT (1) ATE332140T1 (de)
AU (1) AU2533101A (de)
BG (1) BG106914A (de)
BR (1) BR0107630A (de)
CA (1) CA2396098A1 (de)
CO (1) CO5280199A1 (de)
CZ (1) CZ20022282A3 (de)
DE (1) DE60121293T2 (de)
EE (1) EE200200391A (de)
ES (1) ES2267707T3 (de)
HR (1) HRP20020665A2 (de)
HU (1) HUP0300887A2 (de)
IL (1) IL150471A0 (de)
MX (1) MXPA01000464A (de)
NO (1) NO20023392L (de)
PE (1) PE20011121A1 (de)
PL (1) PL357020A1 (de)
SK (1) SK10022002A3 (de)
TR (1) TR200100070A2 (de)
UY (1) UY26530A1 (de)
WO (1) WO2001051055A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1358882A1 (de) * 2002-04-30 2003-11-05 Schering Aktiengesellschaft Verwendung von Prodrogue von Estriol sulfamate zur Behandlung von autoimmunischen Erkrankungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
KR200449618Y1 (ko) * 2008-01-16 2010-07-23 주식회사 코비스 스포츠 그린보수기
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
US11253498B2 (en) * 2017-06-01 2022-02-22 Nexyon Biotech Co., Ltd. Pharmaceutical composition for treatment of bone-related disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen

Also Published As

Publication number Publication date
PE20011121A1 (es) 2001-11-05
ES2267707T3 (es) 2007-03-16
MXPA01000464A (es) 2003-07-21
HRP20020665A2 (en) 2004-12-31
AU2533101A (en) 2001-07-24
HUP0300887A2 (hu) 2003-07-28
BR0107630A (pt) 2002-10-08
CO5280199A1 (es) 2003-05-30
SK10022002A3 (sk) 2002-12-03
WO2001051055A2 (en) 2001-07-19
AR028196A1 (es) 2003-04-30
TR200100070A3 (tr) 2001-08-21
EE200200391A (et) 2003-12-15
BG106914A (en) 2003-01-31
PL357020A1 (en) 2004-07-12
DE60121293T2 (de) 2007-06-28
IL150471A0 (en) 2002-12-01
EP1248626A2 (de) 2002-10-16
NO20023392L (no) 2002-09-16
UY26530A1 (es) 2001-07-31
JP2003519658A (ja) 2003-06-24
EP1248626B1 (de) 2006-07-05
KR20020087930A (ko) 2002-11-23
CN1404394A (zh) 2003-03-19
NO20023392D0 (no) 2002-07-12
CA2396098A1 (en) 2001-07-19
WO2001051055A3 (en) 2002-03-21
DE60121293D1 (de) 2006-08-17
TR200100070A2 (tr) 2001-08-21
CZ20022282A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
DE60226704D1 (de) Acylierte 6,7,8,9-tetrahydro-5h-benzocycloheptenyl-amine und deren pharmazeutische verwendung
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
HUP0700086A2 (en) 2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
DE60123274D1 (de) Pyrrolcarboxamide und pyrrolcarbothioamide und deren agrochemische verwendungen
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
DE69812433D1 (de) Anti-estrogene steroide, pharmazeutische zusammensetzungen und verwendungen davon
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
DE60038304D1 (de) Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
DE60219051D1 (de) Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
ATE320244T1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
DE60142340D1 (de) Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties